The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.
The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.
Results are available within a fortnight.
Online:
www.healthlinx.com.au
Phone: 03 9208 4200
Phone: 03 9208 4200
Related Products
Lumiprobe SynaptoProbe Red dye for visualising synaptic vesicles in living neurons
Lumiprobe's SynaptoProbe Red is an analogue of FM 4-64, a widely used red fluorescent dye for...
Parse Biosciences Evercode Low Input Fixation kits for cells and nuclei
The kits empower researchers who have a small number of starting cells or nuclei who ordinarily...
EpigenTek MethylFlash Hydroxymethylated DNA Quantification Kit (Fluorometric)
The kit is a complete set of optimised buffers and reagents to fluorometrically quantify global...
